InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Doyle John Brendan. Insider active across 1 company, notably Cognition Therapeutics INC. In total, 11 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. History available since 1 May 2023. The latest transaction was disclosed on 16 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Doyle John Brendan is Chief Financial Officer at Cognition Therapeutics INC (XNAS). The record shows 11 filings, and across the 11 sampled filings, activity runs from 2023-05-03 to 2026-04-20, with EUR 9590 of buys and EUR 0 of sells, and the most common transaction nature is Attribution.